| mRNA |
Imatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.0027 |
0.9 |
| mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0026 |
0.9 |
| mRNA |
BRD1835 |
CTRPv2 |
pan-cancer |
AAC |
0.0028 |
0.9 |
| mRNA |
Merck60 |
CTRPv2 |
pan-cancer |
AAC |
0.0022 |
0.9 |
| mRNA |
JW-55 |
CTRPv2 |
pan-cancer |
AAC |
-0.0059 |
0.9 |
| mRNA |
Bax channel blocker |
CTRPv2 |
pan-cancer |
AAC |
0.0027 |
0.9 |
| mRNA |
BMS-345541 |
CTRPv2 |
pan-cancer |
AAC |
0.0025 |
0.9 |
| mRNA |
austocystin d |
CTRPv2 |
pan-cancer |
AAC |
-0.0025 |
0.9 |
| mRNA |
SB-525334 |
CTRPv2 |
pan-cancer |
AAC |
0.0024 |
0.9 |
| mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0019 |
1 |